BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26593978)

  • 1. Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors.
    Grandin C; Hourani ML; Janin YL; Dauzonne D; Munier-Lehmann H; Paturet A; Taborik F; Vabret A; Contamin H; Tangy F; Vidalain PO
    Antiviral Res; 2016 Jan; 125():58-62. PubMed ID: 26593978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
    Chang JS; Wang KC; Shieh DE; Chiang LC
    J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antiviral efficacy against human respiratory syncytial virus using cotton rat and mouse models.
    Van den Berg J; Kwanten L; Roymans D
    Methods Mol Biol; 2013; 1030():365-72. PubMed ID: 23821282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-viral activity of water extract of Paeonia lactiflora pallas against human respiratory syncytial virus in human respiratory tract cell lines.
    Lin TJ; Wang KC; Lin CC; Chiang LC; Chang JS
    Am J Chin Med; 2013; 41(3):585-99. PubMed ID: 23711143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xiao-Qing-Long-Tang (Sho-seiryu-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.
    Chang JS; Yeh CF; Wang KC; Shieh DE; Yen MH; Chiang LC
    J Ethnopharmacol; 2013 May; 147(2):481-7. PubMed ID: 23542148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
    Broadbent L; Parke HG; Ferguson LJ; Millar A; Shields MD; Detalle L; Power UF
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.
    Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM
    Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis.
    Marschall M; Niemann I; Kosulin K; Bootz A; Wagner S; Dobner T; Herz T; Kramer B; Leban J; Vitt D; Stamminger T; Hutterer C; Strobl S
    Antiviral Res; 2013 Dec; 100(3):640-8. PubMed ID: 24149002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiol-Activated Hydrogen Sulfide Donors Antiviral and Anti-Inflammatory Activity in Respiratory Syncytial Virus Infection.
    Bazhanov N; Ivanciuc T; Wu H; Garofalo M; Kang J; Xian M; Casola A
    Viruses; 2018 May; 10(5):. PubMed ID: 29747463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.
    Feng Yeh C; Wang KC; Chiang LC; Shieh DE; Yen MH; San Chang J
    J Ethnopharmacol; 2013 Jul; 148(2):466-73. PubMed ID: 23643542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A.
    Rahman F; Libre C; Oleinikov A; Tcherniuk S
    J Gen Virol; 2021 Aug; 102(8):. PubMed ID: 34342560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimicifuga foetida L. inhibited human respiratory syncytial virus in HEp-2 and A549 cell lines.
    Wang KC; Chang JS; Chiang LC; Lin CC
    Am J Chin Med; 2012; 40(1):151-62. PubMed ID: 22298455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.
    Chang JS; Wang KC; Shieh DE; Hsu FF; Chiang LC
    J Ethnopharmacol; 2012 Jan; 139(1):305-10. PubMed ID: 22120014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication.
    Bailly B; Richard CA; Sharma G; Wang L; Johansen L; Cao J; Pendharkar V; Sharma DC; Galloux M; Wang Y; Cui R; Zou G; Guillon P; von Itzstein M; Eléouët JF; Altmeyer R
    Sci Rep; 2016 May; 6():25806. PubMed ID: 27194388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response.
    Cheung NN; Lai KK; Dai J; Kok KH; Chen H; Chan KH; Yuen KY; Kao RYT
    J Gen Virol; 2017 May; 98(5):946-954. PubMed ID: 28555543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of antiviral compounds on respiratory syncytial virus using a juvenile vervet monkey (Chlorocebus pygerythrus) infection model.
    Houspie L; Stevens H; Ngotho M; Keyaerts E; Ispas G; Verloes R; Van Ranst M; Maes P
    Methods Mol Biol; 2013; 1030():373-82. PubMed ID: 23821283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Syncytial Virus: pathology, therapeutic drugs and prophylaxis.
    Gomez RS; Guisle-Marsollier I; Bohmwald K; Bueno SM; Kalergis AM
    Immunol Lett; 2014 Nov; 162(1 Pt A):237-47. PubMed ID: 25268876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for an intranasal immune response to human respiratory syncytial virus infection in cynomolgus macaques.
    Grandin C; Lucas-Hourani M; Clavel M; Taborik F; Vabret A; Tangy F; Contamin H; Vidalain PO
    J Gen Virol; 2015 Apr; 96(Pt 4):782-792. PubMed ID: 25537374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach.
    Aljabr W; Touzelet O; Pollakis G; Wu W; Munday DC; Hughes M; Hertz-Fowler C; Kenny J; Fearns R; Barr JN; Matthews DA; Hiscox JA
    J Virol; 2016 May; 90(10):4876-4888. PubMed ID: 26656699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.
    Gaillard V; Galloux M; Garcin D; Eléouët JF; Le Goffic R; Larcher T; Rameix-Welti MA; Boukadiri A; Héritier J; Segura JM; Baechler E; Arrell M; Mottet-Osman G; Nyanguile O
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.